Dysfunctional Immune-Privilege In Morbid Obesity: Implications and Effect of Gastric Bypass Surgery

被引:0
作者
D R Cottam
P A Schaefer
G W Shaftan
L D G Angus
机构
来源
Obesity Surgery | 2003年 / 13卷
关键词
MORBID OBESITY; CANCER; APOPTOSIS; CHRONIC INFLAMMATION; L-SELECTIN; FAS ANTIGEN; CD62L; CD95; LYMPHOCYTE; NEUTROPHIL; FLOW CYTOMETRY; IMMUNE PRIVILEGE; BARIATRIC SURGERY; GASTRIC BYPASS;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link.We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Methods: Leukocytes from 25 patients having gastric bypass surgery were compared to 15 normal controls preoperatively and at 1, 3, 6, and 12 months postoperatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD 69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. Results: The percentage of CD95+T cells was significantly elevated from controls (69.4% vs 56%, P=0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P=0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P=0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naiveT cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P=0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. Conclusion: The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.
引用
收藏
页码:49 / 57
页数:8
相关论文
共 50 条
  • [31] Zinc Deficiency after Gastric Bypass for Morbid Obesity: a Systematic Review
    Mahawar, Kamal K.
    Bhasker, Aparna Govil
    Bindal, Vivek
    Graham, Yitka
    Dudeja, Usha
    Lakdawala, Muffazal
    Small, Peter K.
    OBESITY SURGERY, 2017, 27 (02) : 522 - 529
  • [32] Effects of gastric bypass for morbid obesity on Barrett esophagus
    Pereira C, Nicolas
    Csendes J, Attila
    Smok S, Gladys
    Burgos L, Ana Maria
    Nunez B, Solange
    REVISTA CHILENA DE CIRUGIA, 2012, 64 (02): : 155 - 160
  • [33] Clinical experience using the computerized digital stapling system in open gastric-bypass surgery for morbid obesity
    Liem, RK
    Niloff, PH
    OBESITY SURGERY, 2003, 13 (06) : 837 - 841
  • [34] Gastric Actinomycosis: a Rare Complication after Gastric Bypass for Morbid Obesity
    M J Fernández-Aceñero
    V Silvestre
    R Fernández-Roldán
    L Cortés
    G García-Blanch
    Obesity Surgery, 2004, 14 : 1012 - 1015
  • [35] Gastric actinomycosis:: Gastric bypass for a rare complication after morbid obesity
    Fernández-Aceñero, MJ
    Silvestre, V
    Fernández-Roldán, R
    Corté, L
    García-Blanch, G
    OBESITY SURGERY, 2004, 14 (07) : 1012 - 1015
  • [36] Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
    Aaseth, Jan O.
    Rootwelt, Helge
    Retterstol, Kjetil
    Hestad, Knut
    Farup, Per G.
    NUTRIENTS, 2022, 14 (12)
  • [37] Postoperative Osteoporosis in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
    Aaseth, Jan O.
    Alexander, Jan
    NUTRIENTS, 2023, 15 (06)
  • [38] The role of laparoscopic modified antireflux monoanastomotic gastric bypass in the treatment of morbid obesity
    Klymenko, A. V.
    Nikolaiev, M. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2022, 24 (06) : 721 - 727
  • [39] Predictors, Treatment, and Outcomes of Gastrojejunostomy Stricture after Gastric Bypass for Morbid Obesity
    Mark C. Takata
    Ruxandra Ciovica
    John P. Cello
    Andrew M. Posselt
    Stanley J. Rogers
    Guilherme M. Campos
    Obesity Surgery, 2007, 17 : 878 - 884
  • [40] Helicobacter pylori Infection in Patients Undergoing Gastric Bypass Surgery for Morbid Obesity
    Andrew A Renshaw
    Jorge R Rabaza
    Anthony M Gonzalez
    Juan-Carlos Verdeja
    Obesity Surgery, 2001, 11 : 281 - 283